Skip to main content
. 2017 Mar 13;8(18):29865–29886. doi: 10.18632/oncotarget.16168

Table 5. Hazard ratios for disease-free survival and overall survival in orthotopic U251 models.

Treatments Compared Disease-free Survival Overall Survival
HR (95% CI) P Value HR (95% CI) P Value
TMZ vs VSR 2.0 (0.9–5.5) 0.06 (NS) 3.0 (1.0–8.8) 0.0446
RT vs VSR + RT 3.5 (1.2–9.9) 0.0007 9.9 (2.9–34.1) < 0.0001
VSR vs VSR + RT 2.4 (1.1–8.8) 0.0244 4.5 (2.2–22.5) 0.0001
VSR vs TMZ + RT 1.2 (0.4–3.2) 0.66 (NS) 1.5 (0.5–3.0) 0.78 (NS)
VSR + RT vs TMZ + RT 2.5 (1.0–6.2) 0.0088 3.7 (1.2–11.0) 0.0198

CI: confidence interval; HR: hazard ratio; NS: not significant; RT: radiotherapy; TMZ: temozolomide; VSR: vosaroxin.